Ibex Medical Analytics
Tel Aviv-yafo
About Ibex Medical Analytics
Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis, and machine learning, and apply it to cancer diagnostics in digital pathology. Today, Ibex is a multidisciplinary team comprised of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $118.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2023)
- Website: ibex-ai.com
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Health Diagnostics, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/ibex-medical-analytics-86856 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.